Abstract
Little is known about the practices of primary care physicians regarding the prescribing of antidepressants during pregnancy. An anonymous survey was administered to a group of nonrandomly selected Australian general practitioners (n = 61 out of 77) and randomly selected Canadian family physicians (n = 35 out of 111). Responses to a hypothetical scenario and questions regarding beliefs about the use of antidepressant medication during pregnancy were collected. Physicians from both countries feel strongly that antidepressant use during pregnancy is a decision complicated by conflicting reports of safety and risk.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alwan S, Reefhuis J, Rasmussen S, Olney R, Friedman J, NBDP Study Group (2007) Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356:2684–2692
Andrade S, Raebel M, Brown J, Lane K, Livingston J, Boudreau D, Rolnick S, Roblin D, Smith D, Willy M, Staffa J, Platt R (2008) Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 198(194):e1–e5
Andrade S, McPhillips H, Loren D, Raebel M, Lane K, Livingston J, Boudreau D, Smith D, Davis R, Willy M, Platt R (2009) Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 18:246–252
Bakker M, Kölling P, Van Den Berg P, De Walle H, De Jong Van Den Berg L (2008) Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from The Netherlands. Brit J Clin Pharmacol 65:600–606
Buist A, Bilszta J, Barnett B, Milgrom J, Condon J, Hayes B, Brooks J (2005) Recognition and management of perinatal depression in general practice: a survey of GPs and postnatal women. Aust Fam Physician 34:787–790
Buist A, Bilszta J, Milgrom J, Barnett B, Hayes B, Austin M-P (2006) Health professional’s knowledge and awareness of perinatal depression: results of a national survey. Women Birth 19:11–16
Cohen L, Altshuler L, Harlow B, Nonacs R, Newport D, Viguera A, Suri R, Burt V, Hendrick V, Reminick A, Loughead A, Vitonia A, Stowe Z (2006) Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. J Am Med Assoc 295:499–507
Cooper W, Pont M, Ray W (2007) Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 196:e1–e5
Davis L, Rubanowice D, McPhillips H, Raebel M, Andrade S, Smith D, Ulcickas Yood M, Platt R (2007) Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf 16:1086–1094
Einarson T, Einarson A (2005) Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 14:823–827
Einarson A, Selby P, Koren G (2001) Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. J Psychiatry Neurosci 26:44–48
Einarson A, Choi J, Einarson T, Koren G (2009) Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry 54:242–246
Freeman M (2007) Antenatal depression: navigating the treatment dilemmas. Am J Psychiatry 164:1162–1165
Kallen B, Olausson P (2007) Maternal use of selective serotonin reuptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 79:301–308
Louik C, Lin A, Werler M, Hernandez-Diaz S, Mitchell A (2007) First trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356:2675–2683
Lund N, Pedersen L, Henriksen T (2009) Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med 163:949–954
Malm H, Kalukka T, Neuvonen P (2005) Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 106:1289–1296
Moses-Kolko E, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner K (2005) Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. J Am Med Assoc 293:2372–2383
Nevin A, Christopher P, Nulman P, Koren G, Einarson A (2002) A survey of physicians knowledge regarding awareness of maternal alcohol use and the diagnosis of FAS. BMC Fam Prac 3:2
Pearlstein T (2008) Perinatal depression: treatment options and dilemmas. J Psychiatry Neurosci 33:302–318
Ramos E, St-Andre M, Oraichi D, Berard A (2008) Duration of antidepressant use during pregnancy and risk of major congenital malformations. Br J Psychiatry 192:344–350
Reis M, Källén B (2010) Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 40:1723–1722
Tsuchiya S, Einarson A (2007) Physicians’ participation in research. Can Med Assoc J 176:18
Wichman C, Fothergill A, Moore K, Lang T, Heise R, Watson W (2008) Recent trends in selective serotonin reuptake inhibitor use in pregnancy. J Clin Psychopharmacol 28:714–716
Yonkers K, Wisner K, Stewart D, Oberlander T, Dell D, Stotland N, Ramin S, Chaudron L, Lockwood C (2009) The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol 114:703–713
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bilszta, J.L.C., Tsuchiya, S., Han, K. et al. Primary care physician’s attitudes and practices regarding antidepressant use during pregnancy: a survey of two countries. Arch Womens Ment Health 14, 71–75 (2011). https://doi.org/10.1007/s00737-010-0197-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00737-010-0197-8